Chad Lagrange, MD
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,050 of the $7,213 with a category attached, or 83.9%. Integer Holdings Corporation accounts for 83.9% of it on its own, with 8 other manufacturers making up the rest.
Across 21 payments — averaging $343.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integer Holdings Corporation$6K
- Intuitive Surgical$679
- Palette Life Sciences, Inc.$178
- Myovant Sciences Inc.$118
- Urogen Pharma, Inc.$54
- KARL Storz Endoscopy-america$54
- plus $81 from 3 others
What the payments were for
- Consulting fees$6,05084%
- Travel & lodging$5397%
- Food & beverage$6239%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integer Holdings Corporation | 6 | $6,050 |
| Intuitive Surgical | 6 | $679 |
| Palette Life Sciences, Inc. | 1 | $178 |
| Myovant Sciences Inc. | 1 | $118 |
| Urogen Pharma, Inc. | 2 | $54 |
| KARL Storz Endoscopy-america | 2 | $54 |
| Boston Scientific | 1 | $44 |
| Dendreon Pharmaceuticals LLC | 1 | $36 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZIPWIRE$3,050
- PTFE UROLOGIC GUIDEWIRE$3,050
- M WIRE$1,200
- MDR CER$1,000
- MDR$800
- Da Vinci Surgical System$560
- ORGOVYX$118
How this compares
$7,213 in reported general payments places this provider in the 65th percentile of 79 urology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 55 | $38,538 |
| Testosterone | 29 | $5,938 |
| Tamsulosin Hcl | 187 | $2,264 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 61 | $2,212 |
| Oxybutynin Chloride ErOxybutynin Chloride | 106 | $1,605 |
| Trospium Chloride | 27 | $1,355 |
| Testosterone Cypionate | 23 | $767 |
| Finasteride | 76 | $725 |
| Bicalutamide | 31 | $567 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 30 | $358 |
| Solifenacin Succinate | 11 | $250 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $180 |
| Potassium Chloride | 12 | $114 |
| Oxybutynin Chloride | 12 | $77 |
| Oxycodone Hcl | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other urology in Omaha
- John BishayOmaha$138K
- Rebecca McCreryOmaha$71K
- Judson DaviesOmaha$67K
- Stefanie BolteOmaha$59K
- Michael FeloneyOmaha$29K
- Andrew TrainerOmaha$12K
- Stephen LeslieOmaha$12K
- Jon MortonOmaha$11K
- Brett HillOmaha$11K
- John HorganOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.